---
category: trading
circular_id: ceb421e4d3928807
date: '2025-08-01'
description: Settlement calendar for acquisition window takeover of PHARMAIDS PHARMACEUTICALS
  LIMITED from August 4-18, 2025 with settlement on September 1, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={BC529EBF-3BF0-4983-BED0-F8579D3C456F}&noticeno=20250801-27&dt=08/01/2025&icount=27&totcount=73&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Takeover offer with specific settlement procedures affecting shareholders
  of PHARMAIDS PHARMACEUTICALS LIMITED
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250801-27&attachedId=
processing:
  attempts: 1
  content_hash: a0ce5db661d4c507
  processed_at: '2025-08-01T15:38:08.725692'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-01T11:28:31+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={BC529EBF-3BF0-4983-BED0-F8579D3C456F}&noticeno=20250801-27&dt=08/01/2025&icount=27&totcount=73&flag=0
severity: high
source: bse
stocks:
- PHARMAIDS
tags:
- takeover
- settlement
- pharmaids-pharmaceuticals
- acquisition-window
- early-pay-in
title: Settlement Schedule for PHARMAIDS PHARMACEUTICALS LIMITED Takeover Offer
---

## Summary

BSE has announced the settlement schedule for the Offer to Buy â€“ Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LIMITED. The bidding period runs from August 4-18, 2025, with obligation download on August 29, 2025, and final settlement on September 1, 2025.

## Key Points

- Settlement Type: Takeover (Settlement No. 2025067)
- Bid Period: August 4, 2025 to August 18, 2025
- Demat shares must be delivered through Early Pay-in mechanism only
- Market Type "(Takeover)" and settlement No. 2025067 to be used in depository systems
- Early pay-in securities will be earmarked/blocked in client accounts
- No EPN file upload required by members and custodians

## Regulatory Changes

No new regulatory changes introduced. Process follows existing Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange as per Notice No. 20200528-32 dated May 28, 2020.

## Compliance Requirements

- Members/Custodians must use Early Pay-in of Shares mechanism through both depositories
- Must specify Market Type "(Takeover)" and settlement No. 2025067 in depository system
- Early pay-in must be completed sufficiently in advance before BSE OTB bidding window closure
- Members must refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges

## Important Dates

- **Bid Start Date**: August 4, 2025
- **Bid End Date**: August 18, 2025
- **Obligation Download**: August 29, 2025
- **Settlement Date**: September 1, 2025

## Impact Assessment

High impact for PHARMAIDS PHARMACEUTICALS LIMITED shareholders and trading members. The takeover offer provides an acquisition window for shareholders to tender their shares. Proper adherence to early pay-in procedures is critical for successful settlement. Members must ensure timely completion of depository processes to avoid settlement failures.